Ionis Pharma Lower Off Positive News Related To Alnylam's RNAi Drug

By: via Benzinga
Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares are trading lower by $5.70 (9 percent)at $52.37 in Wednesday's session. The sharp ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.